1. 2190 Discovery of new molecular subtypes of non-hypermutated metastatic colorectal cancer (mCRC) through a next-generation sequencing (NGS) approach. (September 2015) Authors: Pietrantonio, F.; Perrone, F.; Cremolini, C.; Orlandi, A.; Niger, M.; Caporale, M.; Berenato, R.; Antoniotti, C.; Loupakis, F.; Tamborini, E.; Milione, M.; Settanni, G.; Busico, A.; De Braud, F.; Di Bartolomeo, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2366 Metronomic capecitabine and bevacizumab is an active combination in patients with relapsed peritoneal pseudomyxoma. (September 2015) Authors: Maggi, C.; De Braud, F.; Di Bartolomeo, M.; Perrone, F.; Tamborini, E.; Milione, M.; Deraco, M.; Kusamura, S.; Baratti, D.; Berenato, R.; Caporale, M.; Consonni, P.V.; Niger, M.; Bossi, I.; Leo, E.; Pelosi, G.; Pietrantonio, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors. (December 2022) Authors: Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2643 Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and translational findings of an open-label, single group, phase 2 study. (September 2015) Authors: Necchi, A.; Giannatempo, P.; Mariani, L.; Raggi, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T.; Stagni, S.; Calareso, G.; Togliardi, E.; Colecchia, M.; Busico, A.; Perrone, F.; Pelosi, G.; Maffezzini, M.; Salvioni, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3316 Non-melanoma skin cancer treated with HDR Brachytherapy and Valencia applicator in elderly patients. (September 2015) Authors: Delishaj, D.; Manfredi, B.; Laliscia, C.; Lombardo, E.; Cantarella, M.; Montrone, S.; Perrone, F.; Coraggio, G.; Cocuzza, P.; Ursino, S.; Pasqualetti, F.; Fabrini, M.G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. (December 2016) Authors: Locati, L.D.; Perrone, F.; Cortelazzi, B.; Bergamini, C.; Bossi, P.; Civelli, E.; Morosi, C.; Lo Vullo, S.; Imbimbo, M.; Quattrone, P.; Dagrada, G.P.; Granata, R.; Resteghini, C.; Mirabile, A.; Alfieri, S.; Orlandi, E.; Mariani, L.; Saibene, G.; Pilotti, S.; Licitra, L. Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma. (July 2016) Authors: Perrone, F.; Bossi, P.; Cortelazzi, B.; Dagrada, G.P.; Paielli, N.; Licitra, L.; Pilotti, S. Journal: Oral oncology Issue: Volume 58(2016:Jul.) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. (26th September 2015) Authors: Cecere, S.C.; Daniele, G.; Lorusso, D.; Scambia, G.; Nicoletto, M.O.; Breda, E.; Colombo, N.; Artioli, G.; Daniele, B.; Lo Re, G.; Raspagliesi, F.; Chiappa, V.; Salutari, V.; Ferrandina, G.; Greggi, S.; Baldoni, A.; Piccirillo, M.C.; Fossati, R.; Perrone, F.; Pignata, S. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dissecting heterogeneity and molecular mechanisms involved in paranasal sinus cancer. (December 2016) Authors: De Cecco, L.; Granata, R.; Orlandi, E.; Fallai, C.; Licitra, L.; Giannoccaro, M.; Perrone, F.; Pilotti, S.; Quattrone, P.; Facco, C.; Sessa, F.; Turri-Zanoni, M.; Battaglia, P.; Castelnuovo, P.; Antognoni, P.; Paielli, N.; Tonella, L.; Canevari, S.; Bossi, P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. (July 2018) Authors: Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P.A.; Locati, L.D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗